Utpal Koppikar
2019
In 2019, Utpal Koppikar earned a total compensation of $2.5M as Chief Financial Officer at Atara Biotherapeutics, a 40% decrease compared to previous year.
Compensation breakdown
| Bonus | $155,606 |
|---|---|
| Option Awards | $909,080 |
| Salary | $439,875 |
| Stock Awards | $1,034,714 |
| Other | $895 |
| Total | $2,540,170 |
Koppikar received $1M in stock awards, accounting for 41% of the total pay in 2019.
Koppikar also received $155.6K in bonus, $909.1K in option awards, $439.9K in salary and $895 in other compensation.
Rankings
In 2019, Utpal Koppikar's compensation ranked 4,785th out of 13,971 executives tracked by ExecPay. In other words, Koppikar earned more than 65.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,785 out of 13,971 | 66th |
Division Manufacturing | 1,782 out of 5,695 | 69th |
Major group Chemicals And Allied Products | 619 out of 2,194 | 72nd |
Industry group Drugs | 521 out of 1,880 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 113 out of 389 | 71st |
Source: SEC filing on April 22, 2020.
Koppikar's colleagues
We found five more compensation records of executives who worked with Utpal Koppikar at Atara Biotherapeutics in 2019.
2019
Isaac Ciechanover
Atara Biotherapeutics
Chief Executive Officer
2019
Pascal Touchon
Atara Biotherapeutics
Chief Executive Officer
2019
Dietmar Berger
Atara Biotherapeutics
Former Global Head of Research & Development
2019
Joseph Newell
Atara Biotherapeutics
EVP, Chief Technical Operations Officer
2019
Mina Kim
Atara Biotherapeutics